Global Arterial Cannula Market Size To Exceed USD 46.9 Billion By 2035 | CAGR Of 7.35%
Category: HealthcareGlobal Arterial Cannula Market Size To Exceed USD 46.9 Billion By 2035
According to a research report published by Spherical Insights & Consulting, The Global Arterial Cannula Market Size is expected to Grow from USD 21.5 Billion in 2024 to USD 46.9 Billion by 2035, at a CAGR of 7.35% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 200 pages with 100 Market data tables and figures & charts from the report on the “Global Arterial Cannula Market Size, Share, and COVID-19 Impact Analysis, By Size (14-16 Fr, 17-19 Fr, 20-22 Fr, 23-25 Fr, 26-28 Fr, 29-31 Fr, 32-34 Fr, and 35-36 Fr), By Application (Extracorporeal Membrane Oxygenation (ECMO), Cardiopulmonary Bypass Surgery, and Others), By End-Use (Hospitals, Ambulatory Surgical Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.” Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/arterial-cannula-market
The arterial cannula market is the industry focusing on the manufacturing, distribution, and sale of arterial cannulas, which are thin, flexible tubes used for accessing and monitoring patients’ arterial systems. An arterial cannula serves as an invasive means to more accurately measure blood pressure and arterial pressure than non-invasive means. An increasing integration of AI-based systems for precise management of cardiovascular disorders, including atrial fibrillation and coronary artery disease (CAD), is escalating the market growth opportunities. The growing prevalence of chronic diseases, including cardiovascular disorders, diabetes, stroke, and cancer contributing to driving the market demand. Advanced healthcare infrastructure, as well as increasing use of respiratory & cardiac support in critical care settings, is promoting the market growth. On the contrary, the increased cost of cardiac treatment and surgery, stringent regulations, potential risks, and complications associated with the use of arterial cannula are challenging the market.
The 20-22 Fr segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the size, the arterial cannula market is divided into 14-16 Fr, 17-19 Fr, 20-22 Fr, 23-25 Fr, 26-28 Fr, 29-31 Fr, 32-34 Fr, and 35-36 Fr. Among these, the 20-22 Fr segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The widespread application of 20-22 Fr size arterial cannula in cardiac surgery and ECMO, along with its rising demand, especially during the pandemic, is driving the market growth.
The extracorporeal membrane oxygenation (ECMO) segment dominated the market with the maximum share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the application, the arterial cannula market is divided into extracorporeal membrane oxygenation (ECMO), cardiopulmonary bypass surgery, and others. Among these, the extracorporeal membrane oxygenation (ECMO) segment dominated the market with the maximum share in 2024 and is projected to grow at a substantial CAGR during the forecast period. The growing prevalence of lung diseases and ECMO, is contributing to driving the market demand for arterial cannula.
The hospitals segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the end-use, the arterial cannula market is divided into hospitals, ambulatory surgical centers, and others. Among these, the hospitals segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. There is an increasing research and innovation activity, along with growing investment for promoting products and services among hospitals. The growing number of surgeries, along with the availability of skilled professionals in hospital care settings, is contributing to propelling the market.
North America is expected to hold the majority share of the global arterial cannula market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global arterial cannula market during the forecast period. An increasing number of surgical procedures, driving the demand for arterial cannula for blood pressure monitoring, blood sampling, or administration of medications, is propelling the market. Additionally, an upsurge in arterial cannula designs and applications for enhancing patient safety and clinical outcomes is propelling the market growth.
Asia Pacific is anticipated to grow at the fastest pace in the global arterial cannula market during the forecast period. The presence of improved healthcare infrastructure with increased accessibility of advanced medical technologies and emphasis on minimally invasive procedures significantly contributes to propelling the market growth. Further, an increasing prevalence of cardiovascular diseases is anticipated to drive the market demand for arterial cannula.
Europe is anticipated to hold a substantial share of the arterial cannula market during the projected timeframe. The increasing number of surgical procedures, healthcare establishments, and R&D investments by government and non-government organizations are several factors that are responsible for driving the market growth. The region’s growing elderly population is driving the demand for cardiovascular interventions, which ultimately results in propelling the arterial cannula market.
Major vendors in the global arterial cannula market are Medtronic, plc., LivaNova plc, Edward Lifesciences, Getinge AB, Fresenius Medical Care, BD, Nipro Corp., Andocor, Freelife Medical GmbH, Surgical Holdings, Kangxin Medical, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In September 2024, Shockwave Medical Inc., part of Johnson & Johnson MedTech and a global leader in the field of circulatory restoration, announced the full U.S. launch of the Shockwave E8 Peripheral IVL Catheter, following clearance by the U.S. Food and Drug administration (FDA).
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the arterial cannula market based on the below-mentioned segments:
Global Arterial Cannula Market, By Size
- 14-16 Fr
- 17-19 Fr
- 20-22 Fr
- 23-25 Fr
- 26-28 Fr
- 29-31 Fr
- 32-34 Fr
- 35-36 Fr
Global Arterial Cannula Market, By Application
- Extracorporeal Membrane Oxygenation (ECMO)
- Cardiopulmonary Bypass Surgery
- Others
Global Arterial Cannula Market, By End-Use
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Arterial Cannula Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?